Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

Boron-10 (10B) concentrations were measured in 107 surgical samples from 15 patients with glioblastoma multiforme who were infused with 95 atom% 10B-enriched p-boronophenylalanine (BPA) intravenously for 2 h just prior to surgery at doses ranging from 98 to 290 mg BPA/kg body weight. The blood 10B concentration reached a maximum at the end of the infusion (ranging from 9.3 to 26.0 microg 10B/g) and was proportional to the amount of BPA infused. The boron concentrations in excised tumor samples ranged from 2.7 to 41.3 microg 10B/g over the range of administered BPA doses and varied considerably among multiple samples from individual patients and among patients at the same BPA dose. A morphometric index of the density of viable-appearing tumor cells in histological sections obtained from samples adjacent to, and macroscopically similar to, the tumor samples used for boron analysis correlated linearly with the boron concentrations. From that correlation it is estimated that 10B concentrations in glioblastoma tumor cells were over four times greater than concurrent blood 10B concentrations. Thus, in the dose range of 98 to 290 mg BPA/kg, the accumulation of boron in tumor cells is a linear function of BPA dose and the variations observed in boron concentrations of tumor specimens obtained surgically are largely due to differences in the proportion of nontumor tissue (i.e. necrotic tissue, normal brain) present in the samples submitted for boron analysis. The tumor:blood 10B concentration ratio derived from this analysis provides a rationale for estimating the fraction of the radiation dose to viable tumor cells resulting from the boron neutron capture reaction based on measured boron concentrations in the blood at the time of BNCT without the need for analysis of tumor samples from individual patients.

[1]  J H Goodman,et al.  Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. , 1997, Cancer research.

[2]  H. Snyder,et al.  Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1 , 1958 .

[3]  R. Bergland,et al.  Boron Neutron Capture Therapy of Glioblastoma Multiforme Using the p-Boronophenylalanine-Fructose Complex and Epithermal Neutrons , 1994 .

[4]  P. Gavin,et al.  Bioavailability of Intravenous Formulations of P-Boronophenylalanine in Dog and Rat , 1993 .

[5]  R. Barth,et al.  Boron neutron capture therapy of cancer. , 1990, Cancer research.

[6]  D. R. Smith,et al.  Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy. , 1996, Cancer research.

[7]  B. Bennett,et al.  Subcellular localization of p-boronophenylalanine-delivered boron-10 in the rat 9L gliosarcoma: cryogenic preparation in vitro and in vivo. , 1994, Radiation research.

[8]  J. Coderre,et al.  Comparative assessment of single-dose and fractionated boron neutron capture therapy. , 1995, Radiation research.

[9]  H. B. Liu,et al.  Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. , 1994, International journal of radiation oncology, biology, physics.

[10]  R. Bergland,et al.  A Phase 1 Trial of Intravenous Boronophenylalanine-Fructose Complex in Patients with Glioblastoma Multiforme , 1996 .

[11]  D. Slatkin.  A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit. , 1991, Brain : a journal of neurology.

[12]  D. Slatkin,et al.  Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. , 1992, Radiation research.

[13]  A. Soloway,et al.  Boron neutron capture therapy for cancer. Realities and prospects , 1992 .

[14]  Y. Mishima.  Cancer Neutron Capture Therapy , 1996, Springer US.

[15]  Y. Mori,et al.  Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. , 1989, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[16]  H. W. Chalkley.  Method for the Quantitative Morphologic Analysis of Tissues , 1943 .

[17]  D. Nigg.  Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy. , 1994, International journal of radiation oncology, biology, physics.

[18]  Floyd J. Wheeler,et al.  Creating and using a type of free-form geometry in Monte Carlo particle transport , 1993 .

[19]  B. Laster,et al.  Microanalytical techniques for boron analysis using the 10B(n,α)7Li reaction , 1986 .